gleevec (Gleevec 400 mg)
Generic Name: imatinib
Pill with imprint gleevec is Orange, Capsule-shape and has been identified as Gleevec 400 mg. It is supplied by Novartis Pharmaceuticals Corporation.
Gleevec is used in the treatment of chronic myelogenous leukemia; chronic eosinophilic leukemia; dermatofibrosarcoma protuberans; acute lymphoblastic leukemia; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Gleevec 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for gleevec
Gleevec
- Generic Name
- imatinib
- Imprint
- gleevec
- Strength
- 400 mg
- Color
- Orange
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-0649
- Inactive Ingredients
-
silicon dioxide,
crospovidone,
ferric oxide red,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol 4000,
magnesium silicate,
hypromelloses,
ferric oxide yellow,
water
Note: Inactive ingredients may vary.
More about Gleevec (imatinib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (34)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- Generic availability
- En español
- Drug class: BCR-ABL tyrosine kinase inhibitors
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.